Morabito Christopher has filed 13 insider transactions across 1 company since January 2024.
Most recent transaction: a disposition of 80000 shares of Astria Therapeutics, Inc. ($ATXS) on January 23, 2026.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 23, 2026 | Astria Therapeutics, Inc. | $ATXS | Morabito Christopher | Chief Medical Officer | D | Stock Option (Right to Buy) | 80000 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.14% |
| Jan. 23, 2026 | Astria Therapeutics, Inc. | $ATXS | Morabito Christopher | Chief Medical Officer | D | Stock Option (Right to Buy) | 262500 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.45% |
| March 21, 2025 | Astria Therapeutics, Inc. | $ATXS | Morabito Christopher | Chief Medical Officer | A | Stock Option (Right to Buy) | 262500 | $0.00 | 262,500.0000 | 56,161,249 | 9999.99% | 0.47% |
| April 1, 2024 | Astria Therapeutics, Inc. | $ATXS | Morabito Christopher | Chief Medical Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 80,000.0000 | 52,294,765 | 11.11% | 0.02% |
| April 1, 2024 | Astria Therapeutics, Inc. | $ATXS | Morabito Christopher | Chief Medical Officer | S | Common Stock | 10000 | $13.59 | 0.0000 | 52,294,765 | 100.00% | 0.02% |
| April 1, 2024 | Astria Therapeutics, Inc. | $ATXS | Morabito Christopher | Chief Medical Officer | M | Common Stock | 10000 | $3.87 | 10,000.0000 | 52,294,765 | 9999.99% | 0.02% |
| Feb. 8, 2024 | Astria Therapeutics, Inc. | $ATXS | Morabito Christopher | Chief Medical Officer | A | Stock Option (Right to Buy) | 175000 | $0.00 | 175,000.0000 | 30,123,316 | 9999.99% | 0.58% |
| Jan. 29, 2024 | Astria Therapeutics, Inc. | $ATXS | Morabito Christopher | Chief Medical Officer | M | Common Stock | 9200 | $3.87 | 9,200.0000 | 30,123,316 | 9999.99% | 0.03% |
| Jan. 29, 2024 | Astria Therapeutics, Inc. | $ATXS | Morabito Christopher | Chief Medical Officer | S | Common Stock | 9200 | $11.15 | 0.0000 | 30,123,316 | 100.00% | 0.03% |
| Jan. 26, 2024 | Astria Therapeutics, Inc. | $ATXS | Morabito Christopher | Chief Medical Officer | S | Common Stock | 800 | $11.02 | 0.0000 | 30,123,316 | 100.00% | 0.00% |
| Jan. 29, 2024 | Astria Therapeutics, Inc. | $ATXS | Morabito Christopher | Chief Medical Officer | M | Stock Option (Right to Buy) | 9200 | $0.00 | 90,000.0000 | 30,123,316 | 9.27% | 0.03% |
| Jan. 26, 2024 | Astria Therapeutics, Inc. | $ATXS | Morabito Christopher | Chief Medical Officer | M | Common Stock | 800 | $3.87 | 800.0000 | 30,123,316 | 9999.99% | 0.00% |
| Jan. 26, 2024 | Astria Therapeutics, Inc. | $ATXS | Morabito Christopher | Chief Medical Officer | M | Stock Option (Right to Buy) | 800 | $0.00 | 99,200.0000 | 30,123,316 | 0.80% | 0.00% |